Report Detail
Global Cardiovascular and Cerebrovascular API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4528764 |
- 13 April, 2023 |
- Global |
- 101 Pages |
- GIR (Global Info Research) |
- Chemical & Material
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
According to our (Global Info Research) latest study, the global Cardiovascular and Cerebrovascular API market size was valued at USD 3161.7 million in 2022 and is forecast to a readjusted size of USD 3779.8 million by 2029 with a CAGR of 2.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.
The key manufacturers are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences etc. Zhejiang Huahai Pharmaceutical Co., Ltd. is the largest producer of cardiovascular and cerebrovascular raw materials in China region market and global market, accounting for more than 10%.
This report is a detailed and comprehensive analysis for global Cardiovascular and Cerebrovascular API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cardiovascular and Cerebrovascular API market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Cardiovascular and Cerebrovascular API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Cardiovascular and Cerebrovascular API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Cardiovascular and Cerebrovascular API market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiovascular and Cerebrovascular API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiovascular and Cerebrovascular API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical and Zhejiang Hisun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Cardiovascular and Cerebrovascular API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sartans Cardiovascular and Cerebrovascular API
Statins Cardiovascular and Cerebrovascular API
Puri Cardiovascular and Cerebrovascular API
Market segment by Application
Oral Drugs
Injection Drugs
Major players covered
Zhuhai Rundu Pharmaceutical
Ningbo Menovo Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Zhejiang Hisun Pharmaceutical
Zhejiang Lepu Pharmaceutical
Zhejiang Jiangbei Pharmaceutical
DR.Reddy
Glenmerk
Cipla
MSN Life Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiovascular and Cerebrovascular API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiovascular and Cerebrovascular API, with price, sales, revenue and global market share of Cardiovascular and Cerebrovascular API from 2018 to 2023.
Chapter 3, the Cardiovascular and Cerebrovascular API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiovascular and Cerebrovascular API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cardiovascular and Cerebrovascular API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiovascular and Cerebrovascular API.
Chapter 14 and 15, to describe Cardiovascular and Cerebrovascular API sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Cardiovascular and Cerebrovascular API
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cardiovascular and Cerebrovascular API Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Sartans Cardiovascular and Cerebrovascular API
- 1.3.3 Statins Cardiovascular and Cerebrovascular API
- 1.3.4 Puri Cardiovascular and Cerebrovascular API
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Cardiovascular and Cerebrovascular API Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Oral Drugs
- 1.4.3 Injection Drugs
- 1.5 Global Cardiovascular and Cerebrovascular API Market Size & Forecast
- 1.5.1 Global Cardiovascular and Cerebrovascular API Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Cardiovascular and Cerebrovascular API Sales Quantity (2018-2029)
- 1.5.3 Global Cardiovascular and Cerebrovascular API Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Zhuhai Rundu Pharmaceutical
- 2.1.1 Zhuhai Rundu Pharmaceutical Details
- 2.1.2 Zhuhai Rundu Pharmaceutical Major Business
- 2.1.3 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 2.1.4 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates
- 2.2 Ningbo Menovo Pharmaceutical
- 2.2.1 Ningbo Menovo Pharmaceutical Details
- 2.2.2 Ningbo Menovo Pharmaceutical Major Business
- 2.2.3 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 2.2.4 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Ningbo Menovo Pharmaceutical Recent Developments/Updates
- 2.3 Zhejiang Huahai Pharmaceutical
- 2.3.1 Zhejiang Huahai Pharmaceutical Details
- 2.3.2 Zhejiang Huahai Pharmaceutical Major Business
- 2.3.3 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 2.3.4 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
- 2.4 Zhejiang Tianyu Pharmaceutical
- 2.4.1 Zhejiang Tianyu Pharmaceutical Details
- 2.4.2 Zhejiang Tianyu Pharmaceutical Major Business
- 2.4.3 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 2.4.4 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Zhejiang Tianyu Pharmaceutical Recent Developments/Updates
- 2.5 Zhejiang Hisun Pharmaceutical
- 2.5.1 Zhejiang Hisun Pharmaceutical Details
- 2.5.2 Zhejiang Hisun Pharmaceutical Major Business
- 2.5.3 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 2.5.4 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
- 2.6 Zhejiang Lepu Pharmaceutical
- 2.6.1 Zhejiang Lepu Pharmaceutical Details
- 2.6.2 Zhejiang Lepu Pharmaceutical Major Business
- 2.6.3 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 2.6.4 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Zhejiang Lepu Pharmaceutical Recent Developments/Updates
- 2.7 Zhejiang Jiangbei Pharmaceutical
- 2.7.1 Zhejiang Jiangbei Pharmaceutical Details
- 2.7.2 Zhejiang Jiangbei Pharmaceutical Major Business
- 2.7.3 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 2.7.4 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Zhejiang Jiangbei Pharmaceutical Recent Developments/Updates
- 2.8 DR.Reddy
- 2.8.1 DR.Reddy Details
- 2.8.2 DR.Reddy Major Business
- 2.8.3 DR.Reddy Cardiovascular and Cerebrovascular API Product and Services
- 2.8.4 DR.Reddy Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 DR.Reddy Recent Developments/Updates
- 2.9 Glenmerk
- 2.9.1 Glenmerk Details
- 2.9.2 Glenmerk Major Business
- 2.9.3 Glenmerk Cardiovascular and Cerebrovascular API Product and Services
- 2.9.4 Glenmerk Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Glenmerk Recent Developments/Updates
- 2.10 Cipla
- 2.10.1 Cipla Details
- 2.10.2 Cipla Major Business
- 2.10.3 Cipla Cardiovascular and Cerebrovascular API Product and Services
- 2.10.4 Cipla Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Cipla Recent Developments/Updates
- 2.11 MSN Life Sciences
- 2.11.1 MSN Life Sciences Details
- 2.11.2 MSN Life Sciences Major Business
- 2.11.3 MSN Life Sciences Cardiovascular and Cerebrovascular API Product and Services
- 2.11.4 MSN Life Sciences Cardiovascular and Cerebrovascular API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 MSN Life Sciences Recent Developments/Updates
3 Competitive Environment: Cardiovascular and Cerebrovascular API by Manufacturer
- 3.1 Global Cardiovascular and Cerebrovascular API Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Cardiovascular and Cerebrovascular API Revenue by Manufacturer (2018-2023)
- 3.3 Global Cardiovascular and Cerebrovascular API Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Cardiovascular and Cerebrovascular API by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Cardiovascular and Cerebrovascular API Manufacturer Market Share in 2022
- 3.4.2 Top 6 Cardiovascular and Cerebrovascular API Manufacturer Market Share in 2022
- 3.5 Cardiovascular and Cerebrovascular API Market: Overall Company Footprint Analysis
- 3.5.1 Cardiovascular and Cerebrovascular API Market: Region Footprint
- 3.5.2 Cardiovascular and Cerebrovascular API Market: Company Product Type Footprint
- 3.5.3 Cardiovascular and Cerebrovascular API Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Cardiovascular and Cerebrovascular API Market Size by Region
- 4.1.1 Global Cardiovascular and Cerebrovascular API Sales Quantity by Region (2018-2029)
- 4.1.2 Global Cardiovascular and Cerebrovascular API Consumption Value by Region (2018-2029)
- 4.1.3 Global Cardiovascular and Cerebrovascular API Average Price by Region (2018-2029)
- 4.2 North America Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
- 4.3 Europe Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
- 4.4 Asia-Pacific Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
- 4.5 South America Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
- 4.6 Middle East and Africa Cardiovascular and Cerebrovascular API Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
- 5.2 Global Cardiovascular and Cerebrovascular API Consumption Value by Type (2018-2029)
- 5.3 Global Cardiovascular and Cerebrovascular API Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
- 6.2 Global Cardiovascular and Cerebrovascular API Consumption Value by Application (2018-2029)
- 6.3 Global Cardiovascular and Cerebrovascular API Average Price by Application (2018-2029)
7 North America
- 7.1 North America Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
- 7.2 North America Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
- 7.3 North America Cardiovascular and Cerebrovascular API Market Size by Country
- 7.3.1 North America Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2029)
- 7.3.2 North America Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
- 8.2 Europe Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
- 8.3 Europe Cardiovascular and Cerebrovascular API Market Size by Country
- 8.3.1 Europe Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Cardiovascular and Cerebrovascular API Market Size by Region
- 9.3.1 Asia-Pacific Cardiovascular and Cerebrovascular API Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Cardiovascular and Cerebrovascular API Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
- 10.2 South America Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
- 10.3 South America Cardiovascular and Cerebrovascular API Market Size by Country
- 10.3.1 South America Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2029)
- 10.3.2 South America Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Cardiovascular and Cerebrovascular API Market Size by Country
- 11.3.1 Middle East & Africa Cardiovascular and Cerebrovascular API Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Cardiovascular and Cerebrovascular API Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Cardiovascular and Cerebrovascular API Market Drivers
- 12.2 Cardiovascular and Cerebrovascular API Market Restraints
- 12.3 Cardiovascular and Cerebrovascular API Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Cardiovascular and Cerebrovascular API and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Cardiovascular and Cerebrovascular API
- 13.3 Cardiovascular and Cerebrovascular API Production Process
- 13.4 Cardiovascular and Cerebrovascular API Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Cardiovascular and Cerebrovascular API Typical Distributors
- 14.3 Cardiovascular and Cerebrovascular API Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cardiovascular and Cerebrovascular API. Industry analysis & Market Report on Cardiovascular and Cerebrovascular API is a syndicated market report, published as Global Cardiovascular and Cerebrovascular API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cardiovascular and Cerebrovascular API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
